Literature DB >> 17559988

Meningococcal carriage and immunity in western Burkina Faso, 2003.

Seydou Yaro1, Yves Traoré, Zekiba Tarnagda, Lassana Sangaré, Berthe-Marie NjanpopLafourcade, Aly Drabo, Helen Findlow, Raymond Borrow, Pierre Nicolas, Bradford D Gessner, Judith E Mueller.   

Abstract

A prospective carriage and serological study was conducted in Burkina Faso during the 2003 meningitis season, which was characterized by hyperendemic Neisseria meningitidis serogroup W135 (NmW135) and serogroup A (NmA) disease. Participants were evaluated five times at monthly intervals. In the presence of moderate NmW135 carriage, we found a low prevalence of putatively protective levels of specific immunoglobulin G (IgG) and serum bactericidal antibody (SBA) against NmW135. Specific IgG concentrations and SBA titers against NmA were relatively high in this recently vaccinated population, while no NmA carriage was detected. NmW135 carriage infrequently induced protective immunity against reference or homologous strains, while natural immunity against NmW135 was frequently lost. A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559988     DOI: 10.1016/j.vaccine.2007.04.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.

Authors:  L V Cooper; P A Kristiansen; H Christensen; A Karachaliou; C L Trotter
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

3.  A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.

Authors:  Abraham Hodgson; Abudulai Adams Forgor; Daniel Chandramohan; Zarifah Reed; Fred Binka; Cornelia Bevilacqua; Dominique Boutriau; Brian Greenwood
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

4.  Neisseria meningitidis serogroup W, Burkina Faso, 2012.

Authors:  Jessica R MacNeil; Isaïe Medah; Daouda Koussoubé; Ryan T Novak; Amanda C Cohn; Fabien V K Diomandé; Denis Yelbeogo; Jean Ludovic Kambou; Tiga F Tarbangdo; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Cynthia Hatcher; Jeni Vuong; Leonard W Mayer; Mamoudou H Djingarey; Thomas A Clark; Nancy E Messonnier
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.